The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Menopause Is a Determinant of Breast Aromatase Expression and Its Associations With BMI, Inflammation, and Systemic Markers
Open accessAbstract
Context: Most estrogen-dependent breast cancers occur after menopause, despite low levels of circulating estrogens. Breast expression of the estrogen-biosynthetic enzyme, aromatase, is proposed to drive breast cancer development after menopause. However, the effects of menopause on breast aromatase expression are unknown. Objective: To determine the effect of menopause on breast aromatase expression in relation to body mass index (BMI), white adipose tissue inflammation (WATi), and systemic markers of metabolic dysfunction. Design, Setting, and Participants: Cross-sectional study of 102 premenopausal (age 27 to 56) and 59 postmenopausal (age 45 to 74) women who underwent mastectomy for breast cancer treatment/prevention. Outcome: Breast tissue was assessed for the presence of crown-like structures and the expression and activity of aromatase. Systemic markers examined include interleukin (IL)-6, insulin, glucose, leptin, adiponectin, high-sensitivity C-reactive protein (hsCRP), cholesterol, and triglycerides. Multivariable analysis was performed for aromatase messenger RNA (mRNA) in relation to BMI, WATi, and blood markers. Results: Postmenopausal women had higher BMI and more breast WATi than premenopausal women. Fasting levels of IL-6, glucose, leptin, hsCRP, and homeostatic model assessment 2 insulin resistance score were higher in the postmenopausal group. BMI was positively correlated with aromatase mRNA in both pre- and postmenopausal women. Aromatase levels were higher in breast tissue of postmenopausal women, with levels being higher in inflamed vs noninflamed, independent of BMI. Adipocyte diameter and levels of leptin, hsCRP, adiponectin, and high-density lipoprotein cholesterol were more strongly correlated with aromatase in postmenopausal than premenopausal women. Conclusions: Elevated aromatase in the setting of adipose dysfunction provides a possible mechanism for the higher incidence of hormone-dependent breast cancer in obese women after menopause.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Posttranscriptional modification of enzymes and other factors relating to local tissue environments, such as adipokines and low-grade inflammation leading to AT dysfunction, are likely to play a role [4,[24][25][26][27].”
From Adipose tissue estrogen production and metabolism in premenopausal women (2021) · cites this paper as [26]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Obesity Is Associated with Inflammation and Elevated Aromatase Expression in the Mouse Mammary Gland
Subbaramaiah, K., Howe, L. R., Bhardwaj, P., Du, B., Gravaghi, C., Yantiss, R. K., Zhou, X. K., Blaho, V. A., Hla, T., Yang, P., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0381 · Cited by 363
Self-citationRetractedCinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A. S., & Obin, M. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500294-jlr200 · Cited by 2,529
Accuracy of body mass index in diagnosing obesity in the adult general population
Romero-Corral, A., Somers, V. K., Sierra-Johnson, J., Thomas, R. J., Collazo-Clavell, M. L., Korinek, J., Allison, T. G., Batsis, J. A., Sert-Kuniyoshi, F. H., & Lopez-Jimenez, F. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.11 · Cited by 1,589
The Emergence of the Metabolic Syndrome with Menopause
Carr, M. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030242 · Cited by 1,449
Muka, T., Oliver-Williams, C., Kunutsor, S., Laven, J. S. E., Fauser, B. C. J. M., Chowdhury, R., Kavousi, M., & Franco, O. H. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2415 · Cited by 826
Understanding weight gain at menopause
Davis, S. R., Castelo-Branco, C., Chedraui, P., Lumsden, M. A., Nappi, R. E., Shah, D., Villaseca, P., & as the Writing Group of the International Menopause Society for World Menopause Day 2012 (2012) · Climacteric · doi:10.3109/13697137.2012.707385 · Cited by 604
American Society of Clinical Oncology Position Statement on Obesity and Cancer
Ligibel, J. A., Alfano, C. M., Courneya, K. S., Demark-Wahnefried, W., Burger, R. A., Chlebowski, R. T., Fabian, C. J., Gucalp, A., Hershman, D. L., Hudson, M. M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.4680 · Cited by 526
Self-citationChanges in Body Composition in Women over Six Years at Midlife: Ovarian and Chronological Aging
Sowers, M., Zheng, H., Tomey, K., Karvonen-Gutierrez, C., Jannausch, M., Li, X., Yosef, M., & Symons, J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1393 · Cited by 470
Morris, P. G., Hudis, C. A., Giri, D., Morrow, M., Falcone, D. J., Zhou, X. K., Du, B., Brogi, E., Crawford, C. B., Kopelovich, L., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0110 · Cited by 465
Self-citationPasqualini, J. R. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.4.1460 · Cited by 433
Cited by
Towards targeting the breast cancer immune microenvironment
Harris, M. A., Savas, P., Virassamy, B., O’Malley, M. M. R., Kay, J., Mueller, S. N., Mackay, L. K., Salgado, R., & Loi, S. (2024) · Nature Reviews Cancer · doi:10.1038/s41568-024-00714-6 · Cited by 363
“Menopausal status can affect systemic hormone levels as oestrogen declines with increasing age; however, local production of oestrogen in the breast from aromatases increases in post-menopausal women 105 .”
Obesity, Type 2 Diabetes, and Cancer Risk
Scully, T., Ettela, A., LeRoith, D., & Gallagher, E. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.615375 · Cited by 256
Metabolic pathways in obesity-related breast cancer
Brown, K. A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00487-0 · Cited by 234
Self-citationBhardwaj, P., Au, C. C., Benito-Martin, A., Ladumor, H., Oshchepkova, S., Moges, R., & Brown, K. A. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.03.002 · Cited by 233
Self-citationThe Role of Chronic Inflammation in the Development of Breast Cancer
Danforth, D. N. (2021) · Cancers · doi:10.3390/cancers13153918 · Cited by 165
Gérard, C., & Brown, K. A. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.014 · Cited by 136
“Clinical studies have translated these experimental observations to women by showing that elevated BMI is associated with high aromatase expression and activity in breast tissue [79, 94, 95, 98].”
Self-citationBlair, C. K., Wiggins, C. L., Nibbe, A. M., Storlie, C. B., Prossnitz, E. R., Royce, M., Lomo, L. C., & Hill, D. A. (2019) · npj Breast Cancer · doi:10.1038/s41523-019-0128-4 · Cited by 139
“The occurrence and severity of breast adipose tissue inflammation is higher in obese compared to normal weight women(34) and in postmenopausal relative to premenopausal women.(35,36) Breast adipose tissue inflammation is associated with elevated aromatase levels, the rate-limiting enzyme in estrogen biosynthesis,(37)…”
BackgroundAdipose tissue estrogen production and metabolism in premenopausal women
Hetemäki, N., Mikkola, T. S., Tikkanen, M. J., Wang, F., Hämäläinen, E., Turpeinen, U., Haanpää, M., Vihma, V., & Savolainen-Peltonen, H. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105849 · Cited by 118
Adipocyte-derived exosomes may promote breast cancer progression in type 2 diabetes
Jafari, N., Kolla, M., Meshulam, T., Shafran, J. S., Qiu, Y., Casey, A. N., Pompa, I. R., Ennis, C. S., Mazzeo, C., Rabhi, N., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abj2807 · Cited by 98
“Adipocyte exosomes encode metabolic status In postmenopausal women with obesity, adipokines and adipocyteinduced estrogen production (14), proinflammatory, CD68+ adipose tissue macrophages in “crown-like structures” (15), and adipocytereleased free fatty acids (7) have each been implicated in ER+ breast tumor progress…”
BackgroundZahid, H., Subbaramaiah, K., Iyengar, N. M., Zhou, X. K., Chen, I., Bhardwaj, P., Gucalp, A., Morrow, M., Hudis, C. A., Dannenberg, A. J., et al. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.273 · Cited by 68
“Obesity is associated with an increase in aromatase expression and activity in the breast tissue of women (3, 4).”
BackgroundSelf-citationFaria, S. S., Corrêa, L. H., Cardoso, G. S. H. R., de Sant’Ana, L. P., Almeida, R. D. N., & Magalhães, K. G. (2020) · Journal of Breast Cancer · doi:10.4048/jbc.2020.23.e35 · Cited by 74
“, 2017 [61] Human Effect of menopause on breast aromatase expression in relation to BMI, CLS and systemic markers of metabolic dysfunction Postmenopausal women had higher BMI and presence of CLS than did premenopausal women”
BackgroundKanaya, N., Chang, G., Wu, X., Saeki, K., Bernal, L., Shim, H.-J., Wang, J., Warden, C., Yamamoto, T., Li, J., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0618-9 · Cited by 64
The role of immune dysfunction in obesity-associated cancer risk, progression, and metastasis
Kulkarni, A., & Bowers, L. W. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03752-z · Cited by 62
The Tumor Promotional Role of Adipocytes in the Breast Cancer Microenvironment and Macroenvironment
Bernard, J. J., & Wellberg, E. A. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.02.006 · Cited by 61
Crown-Like Structures in Breast Adipose Tissue: Early Evidence and Current Issues in Breast Cancer
Maliniak, M. L., Miller‐Kleinhenz, J. M., Cronin-Fenton, D. P., Lash, T. L., Gogineni, K., Janssen, E. A. M., & McCullough, L. E. (2021) · Cancers · doi:10.3390/cancers13092222 · Cited by 55
“The same pilot study and two other studies found that CLS-B were positively associated with aromatase activity in breast tissue [67,71,72].”
BackgroundResultInfluentialA framework to understand diet, physical activity, body weight, and cancer risk
Giovannucci, E. L. (2017) · Cancer Causes & Control · doi:10.1007/s10552-017-0975-y · Cited by 47
Adiposity, Inflammation, and Breast Cancer Pathogenesis in Asian Women
Iyengar, N. M., Chen, I., Zhou, X. K., Giri, D. D., Falcone, D. J., Winston, L. A., Wang, H., Williams, S. K., Lu, Y., Hsueh, T.-H., et al. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-17-0283 · Cited by 46
“Women with WAT inflammation have increased breast tissue levels of aromatase, the ratelimiting enzyme for estrogen biosynthesis, which could locally drive the growth of ERþ tumors (20, 23).”
BackgroundSelf-citationRoles of estrogens, estrogen-like compounds, and endocrine disruptors in adipocytes
Lizcano, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.921504 · Cited by 47
Regulation of aromatase in cancer
Molehin, D., Rasha, F. A., Rahman, R. L., & Pruitt, K. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04099-0 · Cited by 40
Heparanase Accelerates Obesity-Associated Breast Cancer Progression
Hermano, E., Goldberg, R., Rubinstein, A. M., Sonnenblick, A., Maly, B., Nahmias, D., Li, J., Bakker, M. A. H., van der Vlag, J., Vlodavsky, I., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-4058 · Cited by 38
IL‐10 suppresses TNF‐α‐induced expression of human aromatase gene in mammary adipose tissue
Martínez‐Chacón, G., Brown, K. A., Docanto, M. M., Kumar, H., Salminen, S., Saarinen, N., & Mäkelä, S. (2018) · The FASEB Journal · doi:10.1096/fj.201700938rrr · Cited by 35
“Menopause causes changes in microbiota (29) and on the other hand, predisposes to adiposity, as well as low-grade inflammation and increased aromatase inWAT (18, 23, 24).”
BackgroundResultInfluentialSelf-citationExploiting the obesity-associated immune microenvironment for cancer therapeutics
Desharnais, L., Walsh, L. A., & Quail, D. F. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107923 · Cited by 31
Morgan, M. M., Arendt, L. M., Alarid, E. T., Beebe, D. J., & Johnson, B. P. (2019) · The FASEB Journal · doi:10.1096/fj.201802347rrr · Cited by 30
“Anastrazole IC50 was graphed against BMI, which revealed a weak positive trend (r2 = 0.34; P , 0.05) (Fig.”
BackgroundResultInfluentialBarros-Oliveira, M. D. C., Costa-Silva, D. R., dos Santos, A. R., Pereira, R. D. O., Soares, J. M., & da Silva, B. B. (2021) · Clinics · doi:10.6061/clinics/2021/e2846 · Cited by 32
“(9) studied the effect of menopausal status on CYP19A1 mRNA expression in relation to body mass index (BMI), white adipose tissue inflammation (WATi), and systemic markers of metabolic dysfunction in women undergoing mastectomy for treatment or prevention of breast cancer.”
BackgroundInfluentialLaforest, S., Ennour‐Idrissi, K., Ouellette, G., Gauthier, M., Michaud, A., Durocher, F., Tchernof, A., & Diorio, C. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-00676-3 · Cited by 32
“As aromatase expression is higher with increased cell size in our study and in others [14, 19], we were surprised to find no significant relationship between mammary fat cell size and ER+ status.”
BackgroundResultKujundžić, R. N., Stepanić, V., Milković, L., Gašparović, A. Č., Tomljanović, M., & Gall‐Tros̆elj, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051180 · Cited by 31
Diabetes mellitus in breast cancer survivors: metabolic effects of endocrine therapy
Thomas, N. S., Scalzo, R. L., & Wellberg, E. A. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00899-0 · Cited by 36
“Aromatase inhibition is especially important after menopause when adipose tissue, including breast adipose 15 , becomes a primary source of oestrogens in humans.”
BackgroundImpact of Estrogens on the Regulation of White, Beige, and Brown Adipose Tissue Depots
Bernasochi, G. B., Bell, J. R., Simpson, E. R., Delbridge, L. M. D., & Boon, W. C. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180009 · Cited by 36
Melatonin as an Oncostatic Molecule Based on Its Anti-Aromatase Role in Breast Cancer
Jin, Y., Choi, Y. J., Heo, K., & Park, S. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010438 · Cited by 33
“Moreover, elevated leptin, high-sensitivity C-reactive protein (hsCRP), adiponectin, high-density cholesterol levels, and an increased adipocyte diameter have been found in postmenopausal females [56].”
BackgroundAlmekinders, M. M., Schaapveld, M., Thijssen, B., Visser, L. L., Bismeijer, T., Sanders, J., Isnaldi, E., Hofland, I., Mertz, M., Wessels, L. F. A., et al. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00232-w · Cited by 34
Gucalp, A., Zhou, X. K., Cook, E. D., Garber, J. E., Crew, K. D., Nangia, J. R., Bhardwaj, P., Giri, D. D., Elemento, O., Verma, A., et al. (2018) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-17-0354 · Cited by 27
Self-citationSavva, C., Copson, E., Johnson, P., Cutress, R., & Beers, S. A. (2023) · Cancers · doi:10.3390/cancers15092440 · Cited by 27
“Furthermore, adipocyte size and markers of subclinical systemic inflammation are strongly associated with increased levels of aromatase in postmenopausal women [64].”
BackgroundObesity and leptin in breast cancer angiogenesis
Lagarde, C., Thapa, K., Cullen, N. M., Hawes, M. L., Salim, K., Benz, M. C., Dietrich, S. R., Burow, B. E., Bunnell, B. A., Martin, E. C., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1465727 · Cited by 24
Kruse, M. L., Patel, M., McManus, J. M., Chung, Y., Li, X., Wei, W., Bazeley, P. S., Nakamura, F., Hardaway, A., Downs, E. P., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.150403 · Cited by 24
“en, which may lead to changes in local estrogen levels without affecting circulating concentrations (21).”
The Influence of Modifiable Factors on Breast and Prostate Cancer Risk and Disease Progression
Tan, K., & Naylor, M. J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.840826 · Cited by 24
Interconnected Clinical and Social Risk Factors in Breast Cancer and Heart Failure
Sinha, A., Bavishi, A. A., Hibler, E. A., Yang, E. H., Parashar, S., Okwuosa, T. M., DeCara, J. M., Brown, S.-A. N., Guha, A., Sadler, D. B., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.847975 · Cited by 23
“Second, there is increased expression of aromatase, the rate-limiting enzyme in estrogen synthesis, which leads to higher levels of circulating estrogen (28).”
BackgroundArthur, R., Xue, X., Kamensky, V., Chlebowski, R. T., Simon, M. S., Luo, J., Shadyab, A. H., Neuhouser, M. L., Banack, H. R., Ho, G. Y. F., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2690 · Cited by 21
Self-citationObesity-associated Breast Inflammation among Hispanic/Latina Breast Cancer Patients
Greenlee, H., Shi, Z., Hibshoosh, H. H., Giri, D. D., Ahmed, A., Williams, S. K., Falcone, D. J., Winston, L. A., Zhou, X. K., Hudis, C. A., et al. (2018) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0207 · Cited by 22
“Previously using this definition, BWATi severity was shown to be positively associated with aromatase expression in breast tissue (29), providing useful biological information beyond presence or absence of CLS-B.”
MethodSelf-citationObesity, dysbiosis and inflammation: interactions that modulate the efficacy of immunotherapy
Yende, A. S., & Sharma, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1444589 · Cited by 22
The impact of poor metabolic health on aggressive breast cancer: adipose tissue and tumor metabolism
Sankofi, B. M., Valencia-Rincón, E., Sekhri, M., Ponton-Almodovar, A. L., Bernard, J. J., & Wellberg, E. A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217875 · Cited by 18
“These inflammatory foci are also present in women without obesity, but who are classified as metabolically unhealthy (81, 82), illustrating the potential limitation of using BMI to evaluate breast cancer risk on an individual level.”
BackgroundOliver-Baxter, J., Whitford, H. S., Turnbull, D. A., & Bond, M. J. (2018) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2018.06.001 · Cited by 19
Adrenal Steroids and Resistance to Hormonal Blockade of Prostate and Breast Cancer
Michael, P., Roversi, G. A., Brown, K. A., & Sharifi, N. (2022) · Endocrinology · doi:10.1210/endocr/bqac218 · Cited by 17
Self-citationExcess body weight and postmenopausal breast cancer: Emerging molecular mechanisms and perspectives
Nahmias, D., Maimon, O., Meirovitz, A., Sheva, K., Peretz‐Yablonski, T., & Elkin, M. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.09.003 · Cited by 23
Cancer and comorbidity: The role of leptin in breast cancer and associated pathologies
Ray, A. (2018) · World Journal of Clinical Cases · doi:10.12998/wjcc.v6.i12.483 · Cited by 16
Weighing the Risk: effects of Obesity on the Mammary Gland and Breast Cancer Risk
Hillers‐Ziemer, L. E., & Arendt, L. M. (2020) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-020-09452-5 · Cited by 21
CC chemokine ligand 2 (CCL2) stimulates aromatase gene expression in mammary adipose tissue
Martínez‐Chacón, G., Yatkin, E., Polari, L., Dinç, D. D., Peuhu, E., Hartiala, P., Saarinen, N., & Mäkelä, S. (2021) · The FASEB Journal · doi:10.1096/fj.201902485rrr · Cited by 17
Hajirahimkhan, A., Howell, C. E., Bartom, E. T., Dong, H., Lantvit, D. D., Xuei, X., Chen, S., Pauli, G. F., Bolton, J. L., Clare, S. E., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-34762-z · Cited by 18
“6) could be associated with several underlying mechanisms: (1) we have previously shown that LigF is a partial agonist of ER32, and therefore, can behave as an antiestrogen in the presence of E2, thus reducing proliferation, (2) LigF is suggested to have selective ERβ agonist activity, which can suppress ERαdependent…”
BackgroundTargeting systemic and gut microbial metabolism in ER+ breast cancer
Heath, H., Mogol, A. N., Casiano, A. S., Zuo, Q., & Madak‐Erdogan, Z. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.12.008 · Cited by 18
Al-Ghadban, S. I., Isern, S. U., Herbst, K. L., & Bunnell, B. A. (2024) · Biomedicines · doi:10.3390/biomedicines12051042 · Cited by 22
Flanagan, M. R., Doody, D. R., Voutsinas, J. M., Wu, Q. V., Banda, K., Sharifi, N., Li, C. I., & Gadi, V. K. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-12088-w · Cited by 15
Escriche-Escuder, A., Trinidad‐Fernández, M., Pajares, B., Campos, M. I., Alba, E., Vargas, A. I. C., & Roldán‐Jiménez, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-88375-5 · Cited by 13
Nahmias, D., Hermano, E., Sonnenblick, A., Maimon, O., Rubinstein, A. M., Drai, E., Maly, B., Vlodavsky, I., Popovtzer, A., Peretz, T., et al. (2022) · Cells · doi:10.3390/cells11182844 · Cited by 14
Snell, C. E., Gough, M., Liu, C., Middleton, K., Pyke, C., Shannon, C., Woodward, N. E., Hickey, T. E., Armes, J. E., & Tilley, W. D. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0331-3 · Cited by 14
Brantley, K. D., Zeleznik, O. A., Dickerman, B. A., Balasubramanian, R., Clish, C. B., Ávila-Pacheco, J., ROSNER, B. A., Tamimi, R. M., & Eliassen, A. H. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01873-9 · Cited by 14
“Aromatase, active in adipose tissue, contributes to breast cancer development through the conversion of androgens to oestrogens in postmenopausal women [44, 45], and changes in aromatase expression in breast tissue are related to metabolic dysregulation markers such as insulin resistance [46].”
BackgroundJohansson, H. A., Bellerba, F., Macis, D., Bertelsen, B.-E., Guerrieri‐Gonzaga, A., Aristarco, V., Viste, K., Mellgren, G., Cola, G. D., Jemos, C., et al. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-023-07241-2 · Cited by 15
“In postmenopausal women, the rate of transformation of androgens to estrogens is higher amongst obese women [4, 38] and aromatase expression in the breast tissue is directly correlated with BMI and white adipose tissue inflammation [39].”
Ramírez-Expósito, M. J., Martínez-Martos, J. M., Dueñas, B., Navarro-Cecilia, J., & Carrera-González, M. P. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05723-1 · Cited by 11
Furth, P. A., Wang, W., Kang, K., Rooney, B. L., Keegan, G., Muralidaran, V., Zou, X., & Flaws, J. A. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.09.007 · Cited by 11
Zhang, J., Wang, M., Wang, X., Li, Y., Liang, Z., Lin, Y., Liu, Q., Xie, X., Tang, L., & Ren, Z. (2019) · Cancer Medicine · doi:10.1002/cam4.2707 · Cited by 10
Yang, Y., Kelifa, M. O., Yu, B., Herbert, C., Wang, Y., & Jiang, J. (2020) · Global Health Research and Policy · doi:10.1186/s41256-020-00169-w · Cited by 11
Potential therapeutic effects of green tea on obese lipid profile – a systematic review
Macêdo, A. P. A., Gonçalves, M. D. S., Medeiros, J. M. B., David, J. M., Villarreal, C. F., Macambira, S. G., Soares, M. B. P., & Couto, R. D. (2022) · Nutrition and Health · doi:10.1177/02601060211073236 · Cited by 13
“…increased trunk fat mass, waist circumference, visceral and abdominal subcutaneous fat associated with dysfunction metabolic syndrome that increases the risk of metabolic syndrome and a number of comorbidities due to the hormonal changes inherent to this stage of life (Brown et al., 2017).”
BackgroundA study of trends in body morphology, overweight, and obesity in Chinese adults aged 40–59 years
Pan, Q., Zhang, W., Chen, X., Li, Y., & Tu, C. (2025) · BMC Public Health · doi:10.1186/s12889-025-21890-6 · Cited by 9
“Relevant studies have shown that the distribution of body fat in women is affected during menopause, and that menopause is associated with a trend of weight gain, with higher BMI in postmenopausal women [42].”
Shaik, A. N., Kiavash, K., Stark, K., Boerner, J. L., Ruterbusch, J. J., Deirawan, H., Bandyopadhyay, S., Ali‐Fehmi, R., Dyson, G. E., & Coté, M. L. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05983-x · Cited by 10
Ullah, A., Singla, R. K., Cao, D., Chen, B., & Shen, B. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101606 · Cited by 12
Barzin, M., Aryannezhad, S., Bagheri, M., Mahdavi, M., Valizadeh, M., Azizi, F., & Hosseinpanah, F. (2022) · BMC Public Health · doi:10.1186/s12889-022-12810-z · Cited by 9
“Moreover, menopausal changes affect women in their later years, making elderly women more prone to obesity [41, 42].”
BackgroundYousefzadeh, N., Jeddi, S., Shokri, M., Afzali, H., Norouzirad, R., Kashfi, K., & Ghasemi, A. (2021) · Archives of Medical Research · doi:10.1016/j.arcmed.2021.09.007 · Cited by 7
CYP19A1 gene expression in the peripheral blood of Brazilian women with breast cancer relapse
Barros-Oliveira, M. D. C., Costa-Silva, D. R., Campos-Verdes, L. C., Pereira, R. D. O., Silva, R. A., Borges, P. D. T. M., Sousa, E. B., Pinho-Sobral, A. L., Lopes‐Costa, P. V., dos Santos, A. R., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-06978-z · Cited by 7
Goupille, C., Ouldamer, L., Pinault, M., Guimares, C., Arbion, F., Jourdan, M. L., & Frank, P. G. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa432 · Cited by 7
Impact of type 2 diabetes on malignancies of the female reproductive system
Espinoza, C., Veas-Torres, J., Miranda, D. I., & Owen, G. I. (2026) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2026.101459 · Cited by 6
Hybrid Dietary-Blood Inflammatory Profiles and Postmenopausal Breast Cancer: A Case-Control Study
Stasiewicz, B., Wądołowska, L., Biernacki, M., Słowińska, M. A., & Drozdowski, M. (2020) · Nutrients · doi:10.3390/nu12113503 · Cited by 7
“Results from the molecular studies suggest that CRP may be involved in breast cancerogenesis through the increased transcription of genes involved in inflammation and the interaction between inflammation and the estrogen pathway [49,50].”
BackgroundBreast Cancer in Lean Postmenopausal Women Might Have Specific Pathological Features
Uomori, T., Horimoto, Y., Arakawa, A., Iijima, K., & Saito, M. (2019) · In Vivo · doi:10.21873/invivo.11499 · Cited by 5
Johansson, H. A., Guerrieri‐Gonzaga, A., Gandini, S., Bertelsen, B.-E., Macis, D., Serrano, D., Mellgren, G., Lazzeroni, M., Thomas, P. S., Crew, K. D., et al. (2024) · npj Breast Cancer · doi:10.1038/s41523-024-00616-8 · Cited by 5
The Significance of Insulin Resistance in Nondiabetic Breast Cancer Patients
Kundaktepe, B. P., Durmuş, S., Cengız, M., Kundaktepe, F. O., Sözer, V., Papila, Ç., Gelışgen, R., & Uzun, H. (2021) · Journal of Endocrinology and Metabolism · doi:10.14740/jem729 · Cited by 5
“Brown et al [16] showed that FBG levels and HOMA-IR scores were higher in post-M women than in pre-M women.”
BackgroundOghazian, M. B., Shirzad, N., Ahadi, M., Adli, S. E., Mollazadeh, S., & Radfar, M. (2022) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-022-00571-9 · Cited by 3
Bioinformatic Identification of Hub Genes Related to Menopause-Obesity Paradox in Breast Cancer
Hosseinpour, Z., Rezaei–Tavirani, M., & Akbari, M. E. (2023) · Intern J Endocrinol Metab · doi:10.5812/ijem-140835 · Cited by 3
A compendium of adipocyte morphologies across different breast pathologies
Dodson, A., Hanna, K., PALMER, K., Ibrahim, H., Kusserow, K., Eid, R. A., Lip, G., Spence, N., Husain, E. A., Elsberger, B., et al. (2025) · Adipocyte · doi:10.1080/21623945.2025.2568540 · Cited by 2
“These local changes in hormone levels have been reported to influence adipocyte morphology, with a stronger positive correlation between adipocyte diameter and aromatase expression in post-menopausal females compared with pre-menopausal females [20].”
Restrepo, N. A., Jaramillo, C., Gutierrez, A. M. A., González, P., Ramírez‐Posada, M., Restrepo, M. E. M., Lezcano, K. M., Rivas-Bedoya, Y., & Trespalacios, E. M. V. (2023) · Oncología (Ecuador) · doi:10.33821/729 · Cited by 2
Aromatase in adipose tissue exerts an osteoprotective function in male mice via phosphate regulation
Ikedo, A., Yamashita, M., Hoshino, M., Okuno, Y., Koike, M., Uga, M., Tanifuji, K., Segawa, H., Fukumoto, S., & Imai, Y. (2025) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjaf129 · Cited by 3
“33,34 In fact, Cyp19a1 expression levels in WATs were higher than bone tissue and bone marrow adipocytes (Figure S3).”
Hajirahimkhan, A., Bartom, E. T., Chung, C. H., Guo, X., Berkley, K., Hosseinibarkooie, S., Assadi, Z., Weng, S. H. S., Moellering, R., Lee, O., et al. (2025) · International Journal of Cancer · doi:10.1002/ijc.70226 · Cited by 3
Adipocytokine imbalance and breast cancer in obese women
Qteishat, A. A., Aringazina, R. A., Ermakov, D., & Demianenko, E. V. (2023) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_2566_22 · Cited by 2
Maniçoba, A. C. B. N., Neto, C. P. D. O., do Nascimento, J. R., do Nascimento, F. R. F., Brito, H. O., da Costa, R. M. G., Barbosa, M. D. C. L., Faria, M. D. S., Nascimento, M. D. D. S. B., & Brito, L. M. O. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000249 · Cited by 1
“All these changes increase the risk of some types of cancer, like breast cancer, which are promoted by obesity and chronic inflammation (4,5).”
BackgroundHussein, A. A., Baban, R., & Mahdi, Q. A. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns5.10552 · Cited by 1
Aromatase Enzyme Activity and Liver Receptor Homolog-1 Levels in Gestational Diabetes Mellitus
Bayraktar, N., Tas, H., Bayraktar, M., Koyuncu, İ., Sarı, İ., & Uyanıkoğlu, H. (2022) · Current Enzyme Inhibition · doi:10.2174/1573408019666221103145729 · Cited by 1
Adipose Compounds in Breast Tumor Extracellular Matrix
Piccioni, F., & Luca, P. D. (2022) · Biology of extracellular matrix · doi:10.1007/978-3-030-99708-3_12 · Cited by 1
Hajirahimkhan, A., Howell, C. E., Chen, S., Clare, S. E., Pauli, G. F., Khan, S. A., Bolton, J. L., & Dietz, B. M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.06.490985 · Cited by 1
“Estrogen (E1/E2) production in the breast takes place in the pre-adipocyte fibroblasts of the stromal compartment of the breast (3).”
BackgroundInfluentialRamı́rez-Expósito, M. J., Carrera-González, M. P., & Martı́nez-Martos, J. M. (2022) · doi:10.32388/qfrd0a · Cited by 1
Semerdzhieva, N. E., Tsakova, A. D., Hristova, J., Lozanov, V. S., Loznova, V. V., Gospodinova, M. V., Dimitrov, S. I., Atanasov, P. Y., & Chaneva, M. S. (2023) · Preprints.org · doi:10.20944/preprints202310.0059.v1
Semerdzhieva, N. E., Tsakova, A. D., Hristova, J., Lozanov, V. S., Loznova, V. V., Gospodinova, M. V., Dimitrov, S. I., Atanasov, P. Y., & Chaneva, M. S. (2023) · Preprints.org · doi:10.20944/preprints202310.0059.v2
Adipose Tissue Produced Estrogen as Risk Factors for Cancers
Husain, H., Ahmad, R., & Waseem, M. (2021) · Springer eBooks · doi:10.1007/978-981-16-1846-8_2
Deposition of heteroepitaxial layer of cadmium selenide and telluride on indium arsenide
Buttaev, Гасанов, Н. Г., Gasanova, R. N., & Magomedov, K. A. (1986) · Inorg. Mater. (Engl. Transl.); (United States)
The Role of Phorbol Diesters in Mediating Human Placental Aromatase Cytochrome P450 Activity
Odoemelam, C. S., Hunter, E., Eberl, D. T., Busi, B., Ahmad, Z., White, S., & Wilson, P. (2022) · Applied Biosciences · doi:10.3390/applbiosci1030017
The Impact of Hormonal Changes in Elderly Women: A Literature Review
Helda, H., Latifah, M. M., Komalasari, D. P., Utami, F., Rajab, N. M., Utami, R. P., Rahmadani, S. A., Ramadhania, S. A., & Stefani, S. (2024) · JURNAL INFO KESEHATAN · doi:10.31965/infokes.vol22.iss1.1411 · Cited by 4
“Despite low circulating estrogen levels, most breast cancers occurring after menopause are estrogen-dependent, and the risk of breast cancer in these women increases with obesity and metabolic syndrome (Brown et al., 2017).”
BackgroundInfluentialBarzin, M., Aryannezhad, S., Bagheri, M., Mahdavi, M., Valizadeh, M., Azizi, F., & Hosseinpanah, F. (2022) · Figshare · doi:10.6084/m9.figshare.19290034
LIMA, R. S. P., Sousa, J. D. S., de Sousa, D. J. M., Martins, J. A., Pereira, I. C., Monteiro, R. L., Neres, M. S. D. O., Severo, J. S., da Silva, F. C. C., da Silva, M. T. B., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27073173
Drai, E., Nahmias, D., Hermano, E., Yifrach, A., Chen, O., Maimon, O., Popovtzer, A., Peretz, T., Meirovitz, A., & Elkin, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104338 · Cited by 1
“Among those, fibroblasts (expressing aromatase [31,34,44,51–54]) and macrophages (producing tumor-promoting cytokines [33,49,50,52,55]) are recognized as key cell types promoting obesity-associated ER+ BC. Notably, endotoxin at subclinical levels typical for ME selectively triggers prolonged…”
InfluentialZhou, S., Zhao, Y., Cui, X., Niu, Y., & Sabihi, S.-S. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04321-3 · Cited by 1
“Aromatase, the enzyme controlling the rate-limiting step of estrogen production, is consistently upregulated in adipocytes, including those within breast tissue, as a function of both menopausal status and body mass index (BMI) [12–14].”
Carrera-González, M. P., Ramírez-Expósito, M. J., Cueto‐Ureña, C., & Martínez-Martos, J. M. (2026) · Applied Sciences · doi:10.3390/app16125910
Badre, O., Chang, S.-L., Abdous, B., Lemieux, J., Durocher, F., Tchernof, A., & Diorio, C. (2026) · Cancers · doi:10.3390/cancers18152464
“…Forest plot of the correlation between mammary adipocyte diameter and aromatase expression [39,41,43] after excluding the pre-menopausal subgroup [43]; Figure S17: Funnel plot with trim-and-fill method assessing publication bias in the correlation between mammary adipocyte diameter and aromatase…”
InfluentialYuan, J., Zhang, H., Huang, J., Wang, B., Wang, M., & Yang, L. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189733
Metadata
- Authors
- Brown, K. A., Iyengar, N. M., Zhou, X. K., Gucalp, A., Subbaramaiah, K., Wang, H., Giri, D. D., Morrow, M., Falcone, D. J., Wendel, N. K., Winston, L. A., Pollak, M., Dierickx, A., Hudis, C. A., & Dannenberg, A. J.
- Affiliations
- Hudson Institute of Medical Research (AU)
- Memorial Sloan Kettering Cancer Center (US)
- Weill Cornell Medicine (US)
- Departments of Medicine and Oncology, McGill University, Montreal, Quebec, Canada H3T 1E2
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2017-02-16
- Volume
- 102
- Issue
- 5
- Pages
- 1692-1701
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC5443335
- OpenAlex
- W2611395550
- Cited by
- 99
- References
- 46
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 8 · 2023: 10 · 2022: 18 · 2021: 19 · 2020: 10 · 2019: 11 · 2018: 6 · 2017: 4
- FWCI
- 5.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (U54CA210184, R01CA185293, P30CA008748)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- menopause, aromatase mRNA expression, body mass index, white adipose tissue inflammation, crown-like structures, breast cancer, estrogen synthesis, obesity, insulin resistance, leptin, C-reactive protein, adiponectin, postmenopausal women, premenopausal women, mastectomy
- MeSH terms
- Adult, Aged, Aromatase, Blood Glucose, Breast, Breast Neoplasms, C-Reactive Protein, Cholesterol, Female, Humans, Inflammation, Insulin, Insulin Resistance, Cholesterol, HDL, Cholesterol, LDL, Menopause, Middle Aged, RNA, Messenger, Triglycerides, Interleukin-6, Body Mass Index, Multivariate Analysis, Premenopause, Postmenopause, Gene Expression Regulation, Developmental, Leptin, Adiponectin, Adipose Tissue, White
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.